TABLE 1.
STDs | On-Site Services* | Off-Site Offerings | |||
---|---|---|---|---|---|
Testing | Treatment | Extra Genital Examinations | Prescriptions† | Referrals | |
N | n (%) | n (%) | n (%) | n (%) | |
Syphilis | 19 | 7 (36.8) | NA | 6 (31.6) | 11 (57.9) |
Gonorrhea | 19 | 18 (94.7) | 11 (57.9) | 7 (36.8) | 1 (5.2) |
Chlamydia | 19 | 9 (47.4) | 11 (57.9) | 17 (89.5) | 2 (10.5) |
Herpes | 19 | 2 (10.5) | NA | 17 (89.5) | 4 (21.1) |
Hepatitis B | 19 | 1 (5.2) | NA | 2 (10.5) | 16 (84.2) |
Hepatitis C | 18 | 0 | NA | 1 (5.6) | 16 (84.2) |
Bacterial Vaginosis | 18 | 3 (16.7) | NA | 14 (77.8) | 2 (10.5) |
Trichomoniasis | 19 | 4 (21.1) | NA | 18 (94.7) | 1 (5.2) |
N = 19 urgent care centers. Rows nor columns equal 100%.
Includes those services done during initial and follow-up visits to complete treatment.
Numbers in Prescription column may overlap with “on-site” treatment column.
NA, not applicable. Respondents indicated syphilis, HSV, HBV, and HCV were conducted as part of STD panels via blood samples.